IBIO, INC. (IBIO) EBITDA
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$8.37M; Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA (m); Operating income -$9.45M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$5.95M; Depreciation and amortization (m).
- 2025-03-31: Basis Reported; EBITDA (m); Operating income -$4.88M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Reported | (m) | -$8.37M | (m) | $0.00* | (m) | $11.00K* | -$6.08M* | (m) | $3.25M | (m) | $0.00 |
| 2025-12-31 | Reported | (m) | -$9.45M | (m) | $0.00 | (m) | $516.00K* | -$5.24M* | (m) | $4.28M | (m) | $0.00 |
| 2025-09-30 | Reported | (m) | -$5.95M | (m) | $100.00K | (m) | $32.00K | -$5.67M | (m) | $3.55M | (m) | $0.00 |
| 2025-03-31 | Reported | (m) | -$4.88M | (m) | $0.00 | (m) | $14.00K* | -$3.10M* | (m) | $1.91M | (m) | $0.00 |
| 2024-12-31 | Reported | (m) | -$4.42M | (m) | $200.00K | (m) | $1.00K* | -$3.87M* | (m) | $1.88M | (m) | $0.00 |
| 2024-09-30 | Reported | (m) | -$4.11M | (m) | $0.00 | (m) | $0.00 | -$3.71M | (m) | $1.30M | (m) | $0.00 |
| 2024-03-31 | Reported | (m) | -$3.63M | (m) | $0.00* | (m) | $0.00* | -$3.65M* | (m) | $904.00K | (m) | $0.00 |
| 2023-12-31 | Reported | (m) | -$4.50M | (m) | $0.00* | (m) | (m) | -$4.71M* | (m) | $1.53M | (m) | $0.00 |
| 2023-09-30 | Reported | (m) | -$5.10M | (m) | $50.00K | (m) | (m) | -$5.34M | (m) | $1.61M | (m) | $0.00 |
| 2023-03-31 | Reported | (m) | -$6.17M | (m) | (m) | (m) | -$201.00K* | -$3.87M* | (m) | $2.64M | (m) | $0.00 |
| 2022-12-31 | Reported | (m) | -$10.57M | (m) | (m) | (m) | $2.95M* | -$7.63M* | (m) | $2.78M | (m) | $0.00 |
| 2022-09-30 | Reported | (m) | -$7.64M | (m) | $0.00 | (m) | $2.48M | -$13.96M | (m) | $2.55M | (m) | $0.00 |
| 2022-03-31 | Reported | (m) | -$6.79M | (m) | (m) | (m) | $644.00K* | -$5.94M* | $48.00K | $3.27M | (m) | $0.00 |
| 2021-12-31 | Reported | (m) | -$7.23M | (m) | (m) | (m) | $2.13M* | -$10.69M* | $113.00K | $1.86M | (m) | $0.00 |
| 2021-09-30 | Reported | (m) | -$5.22M | (m) | (m) | (m) | $1.12M | -$9.35M | $40.00K | $1.13M | (m) | $0.00 |
| 2021-03-31 | Reported | (m) | -$7.20M | (m) | (m) | (m) | $993.00K* | -$7.35M* | $493.00K | $2.16M | (m) | $0.00* |
| 2020-12-31 | Reported | (m) | -$7.54M | (m) | (m) | (m) | $994.00K* | -$8.42M* | $211.00K | $2.37M | (m) | $0.00* |
| 2020-09-30 | Reported | (m) | -$6.92M | (m) | (m) | (m) | $419.00K | -$7.07M | $107.00K | $1.86M | (m) | $0.00 |
| 2020-03-31 | Reported | (m) | -$4.06M | (m) | (m) | (m) | $69.00K* | -$3.79M* | $86.00K | $1.09M | (m) | $0.00* |
| 2019-12-31 | Reported | (m) | -$3.15M | (m) | (m) | (m) | $202.00K* | -$3.40M* | (m) | $888.00K | (m) | $0.00 |
| 2019-09-30 | Reported | (m) | -$3.85M | (m) | (m) | (m) | $0.00 | -$2.29M | (m) | $977.00K | (m) | $0.00 |
| 2019-03-31 | Reported | (m) | -$3.77M | (m) | (m) | (m) | $128.00K* | -$4.13M* | (m) | $1.45M | (m) | (m) |
| 2018-12-31 | Reported | (m) | -$4.01M | (m) | (m) | (m) | $374.00K* | -$4.67M* | (m) | $1.27M | (m) | $0.00 |
| 2018-09-30 | Reported | (m) | -$3.95M | (m) | (m) | (m) | $274.00K | -$778.00K | (m) | $1.12M | (m) | $0.00 |
| 2018-03-31 | Reported | (m) | -$3.49M | (m) | (m) | (m) | $435.00K* | -$3.50M* | (m) | $966.00K | (m) | (m) |
| 2017-12-31 | Reported | (m) | -$3.43M | (m) | (m) | (m) | $181.00K* | -$3.59M* | (m) | $993.00K | (m) | (m) |
| 2017-09-30 | Reported | (m) | -$3.36M | (m) | (m) | (m) | $96.00K | -$3.02M | (m) | $985.00K | (m) | (m) |
| 2017-03-31 | Reported | (m) | -$3.94M | (m) | (m) | (m) | $270.00K* | -$3.56M* | (m) | $1.14M | (m) | (m) |
| 2016-12-31 | Reported | (m) | -$3.33M | (m) | (m) | (m) | $139.00K* | -$3.56M* | (m) | $1.05M | (m) | (m) |
| 2016-09-30 | Reported | (m) | -$3.15M | (m) | (m) | (m) | $400.00K | -$2.27M | (m) | $820.00K | (m) | (m) |
| 2016-03-31 | Reported | (m) | -$3.07M | (m) | (m) | (m) | $3.00K* | (m) | (m) | $1.05M | (m) | (m) |
| 2015-12-31 | Reported | (m) | -$2.25M | (m) | (m) | (m) | $5.00K* | (m) | (m) | $704.00K | (m) | (m) |
| 2015-09-30 | Reported | (m) | -$1.81M | (m) | (m) | (m) | $0.00 | (m) | (m) | $551.00K | (m) | (m) |
| 2015-03-31 | Reported | (m) | -$1.69M | (m) | (m) | (m) | $0.00* | (m) | (m) | $815.00K | (m) | (m) |
| 2014-12-31 | Reported | (m) | -$1.67M | (m) | (m) | (m) | $1.00K* | (m) | (m) | $731.00K | (m) | (m) |
| 2014-09-30 | Reported | (m) | -$1.42M | (m) | (m) | (m) | $14.00K | (m) | (m) | $1.19M | (m) | (m) |
| 2014-03-31 | Reported | (m) | -$1.29M | (m) | (m) | (m) | $4.00K* | (m) | (m) | $343.00K | (m) | $0.00* |
| 2013-12-31 | Reported | (m) | -$1.64M | (m) | (m) | (m) | $0.00* | $3.11M* | (m) | $585.00K | (m) | $0.00* |
| 2013-09-30 | Reported | (m) | $240.00K | (m) | (m) | (m) | $0.00 | -$911.00K | (m) | $552.00K | (m) | $0.00 |
| 2013-03-31 | Reported | (m) | -$1.86M | (m) | (m) | (m) | $1.00K* | $6.59M* | (m) | $631.00K | (m) | $0.00 |
| 2012-12-31 | Reported | (m) | -$1.70M | (m) | (m) | (m) | (m) | -$1.40M* | (m) | $656.00K | (m) | $0.00* |
| 2012-09-30 | Reported | (m) | -$1.81M | (m) | (m) | (m) | (m) | -$1.29M | (m) | $1.18M | (m) | $0.00 |
| 2012-03-31 | Reported | (m) | -$2.18M | (m) | (m) | (m) | (m) | $2.99M* | (m) | $1.31M | (m) | $0.00 |
| 2011-12-31 | Reported | (m) | -$2.67M | (m) | (m) | (m) | (m) | $3.24M* | (m) | $1.16M | (m) | (m) |
| 2011-09-30 | Reported | (m) | -$2.33M | (m) | (m) | (m) | (m) | -$1.23M | (m) | $1.46M | (m) | (m) |
| 2011-03-31 | Reported | (m) | -$2.89M | (m) | (m) | (m) | (m) | -$2.01M* | (m) | $1.14M | (m) | (m) |
| 2010-12-31 | Reported | (m) | -$1.87M | (m) | (m) | (m) | (m) | -$1.71M* | (m) | $619.54K | (m) | (m) |
| 2010-09-30 | Reported | (m) | -$1.37M | (m) | (m) | (m) | (m) | -$526.23K | (m) | $157.54K | (m) | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$35.14M | (m) | $100.00K | (m) | $578.00K | -$23.22M | (m) | $19.64M | (m) | $0.00 |
| 2025-06-30 | Reported | (m) | -$18.60M | (m) | $400.00K | (m) | $16.00K | -$15.30M | (m) | $8.31M | (m) | $0.00 |
| 2024-06-30 | Reported | (m) | -$16.63M | (m) | $225.00K | (m) | $210.00K | -$18.55M | (m) | $5.18M | (m) | $0.00 |
| 2023-06-30 | Reported | (m) | -$29.34M | (m) | $0.00 | (m) | $5.74M | -$30.44M | (m) | $10.33M | (m) | $0.00 |
| 2022-06-30 | Reported | (m) | -$29.70M | (m) | (m) | (m) | $7.33M | -$37.48M | $216.00K | $9.83M | (m) | $0.00 |
| 2021-06-30 | Reported | (m) | -$31.11M | (m) | (m) | (m) | $4.92M | -$30.06M | $1.46M | $9.99M | (m) | $0.00 |
| 2020-06-30 | Reported | (m) | -$14.00M | (m) | (m) | (m) | $1.08M | -$13.35M | $703.00K | $3.57M | (m) | $0.00 |
| 2019-06-30 | Reported | (m) | -$15.79M | (m) | (m) | (m) | $920.00K | -$13.97M | (m) | $5.47M | (m) | $0.00 |
| 2018-06-30 | Reported | (m) | -$14.23M | (m) | (m) | (m) | $934.00K | -$13.48M | (m) | $3.99M | (m) | $0.00 |
| 2017-06-30 | Reported | (m) | -$14.27M | (m) | (m) | (m) | $1.32M | -$13.16M | (m) | $4.12M | (m) | $0.00 |
| 2016-06-30 | Reported | (m) | -$9.89M | (m) | (m) | (m) | $68.00K | (m) | (m) | $3.16M | (m) | $0.00 |
| 2015-06-30 | Reported | (m) | -$6.67M | (m) | (m) | (m) | $13.00K | (m) | (m) | $3.50M | (m) | $0.00 |
| 2014-06-30 | Reported | (m) | -$3.84M | (m) | (m) | (m) | $4.00K | (m) | (m) | $1.90M | (m) | $0.00 |
| 2013-06-30 | Reported | (m) | -$6.67M | (m) | (m) | (m) | $7.00K | -$4.85M | (m) | $3.43M | (m) | $0.00 |
| 2012-06-30 | Reported | (m) | -$9.33M | (m) | (m) | (m) | $1.00K | -$6.01M | (m) | $4.98M | (m) | $0.00 |
| 2011-06-30 | Reported | (m) | -$9.65M | (m) | (m) | (m) | $1.22K | -$5.34M | (m) | $3.08M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |